Phase I and II Clinicla Trials of Cancer Prevention Agents
Phase I and II Clinicla Trials of Cancer Prevention Agents
批准号:
8340965
负责人:
SHERRY CHOW
金额:
$119.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2014-09-29
关键词:
BiologicalBiological MarkersBreastCancer Prevention TrialCervix UteriChemopreventionChemopreventive AgentChronicClinicalClinical ResearchClinical TrialsContractsDivision of Cancer PreventionDoseDrug KineticsInstitutionIntraepithelial NeoplasiaMalignant NeoplasmsMolecular TargetNational Cancer InstitutePhasePhase I Clinical TrialsPhase II Clinical TrialsPolyphenon EPreventiveProstateResearch InfrastructureResveratrolSafetyServicesSulindacToxic effectTranslational Researchcancer preventioncarcinogenesisclinically relevantdesigndiindolylmethaneinsightnovel
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ARTICLE B.1. BRIEF DESCRIPTION OF SUPPLIES OR SERVICES
The purpose of this procurement is to conduct multiple early phase (Phase 1 and Phase 2) clinical trials of the National Cancer Institute (NCI), Division of Cancer Prevention (DCP)-sponsored cancer preventive agents and to establish the infrastructures composed of one or more collaborating institutions that will perform these trials. The trials will assess the cancer preventive potential of various agents by evaluating the biologic effects of these agents on their molecular targets and by determining clinically relevant correlates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM
-
批准号:10690412
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2019
-
负责人:SHERRY CHOW
-
依托单位:
CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM
-
批准号:10451452
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2019
-
负责人:SHERRY CHOW
-
依托单位:
CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM
-
批准号:10045659
-
项目类别:
-
资助金额:$63.89万
-
财政年份:2019
-
负责人:SHERRY CHOW
-
依托单位:
IGF::OT::IGF R&D- CORE INFRASTRUCTURE SUPPORT
-
批准号:9344509
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2015
-
负责人:SHERRY CHOW
-
依托单位:
IGF::OT::IGF M4OC-PREVENT: METFORMIN FOR ORAL CANCER PREVENTION
-
批准号:9162592
-
项目类别:
-
资助金额:$72.22万
-
财政年份:2015
-
负责人:SHERRY CHOW
-
依托单位:--
A PROSPECTIVE, SINGLE-ARM, OPEN-LABEL, NON-RANDOMIZED, PHASE IIA TRIAL OF A NONAVALENT PROPHYLACTIC HPV VACCINE TO ASSESS IMMUNOGENICITY OF A PRIME AND DEFERRED-BOOSTER DOSING SCHEDULE
-
批准号:9981475
-
项目类别:
-
资助金额:$13.97万
-
财政年份:2015
-
负责人:SHERRY CHOW
-
依托单位:
Contract HHSN261201200031I, 09/24/2012 - 09/23/2017Cancer Prevention Agent Development Program: Early Phase Clinical ResearchTask Order HHSN26100007, 09/24/2014 - 09/23/2015Core Infrastructur
-
批准号:8948629
-
项目类别:
-
资助金额:$58.05万
-
财政年份:2014
-
负责人:SHERRY CHOW
-
依托单位:--
University of Arizona HHSN261201200031I;Task Order
-
批准号:8947593
-
项目类别:
-
资助金额:$15.16万
-
财政年份:2014
-
负责人:SHERRY CHOW
-
依托单位:--
HHSN26120120003 II CLINICAL STUDY OF THE EFFECT OF COMBINED TREATMENT OF ASPIRIN AND ZILEUTON ON BIOMARKERS OF TOBACCO-RELATED CARCINOGENESIS IN CURRENT CMOKERS 08/01/2014 - 07/31/2016
-
批准号:8947595
-
项目类别:
-
资助金额:$87.87万
-
财政年份:2014
-
负责人:SHERRY CHOW
-
依托单位:--
CLINICAL STUDY OF THE EFFECT OF COMBINED TREATMENT OF ASPIRIN AND ZILEUTON ON BIOMARKERS OF TOBACCO-RELATED CARCINOGENESIS IN CURRENT SMOKERS
-
批准号:9915397
-
项目类别:
-
资助金额:$10.26万
-
财政年份:2014
-
负责人:SHERRY CHOW
-
依托单位:
IGF::OT::IGF THE EFFECT OF INTERMITTENT VERSUS CONTINUOUS DOSE ASPIRIN (ASA) IN CURRENT SMOKERS ON NASAL EPITHELIUM GENE EXPRESSION
-
批准号:9162585
-
项目类别:
-
资助金额:$15.68万
-
财政年份:2013
-
负责人:SHERRY CHOW
-
依托单位:--
Phase I and II Clinicla Trials of Cancer Prevention Agents
-
批准号:7943302
-
项目类别:
-
资助金额:$143.2万
-
财政年份:2003
-
负责人:SHERRY CHOW
-
依托单位:
PHASE I AND II CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
-
批准号:7543346
-
项目类别:
-
资助金额:$232.9万
-
财政年份:2003
-
负责人:SHERRY CHOW
-
依托单位:--
海外基金